Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04195906 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study of SNF472 for Calciphylaxis
A Phase 3 study, sponsored by Sanifit Therapeutics S. A..
- Completed
- Registry status
- Phase 3
- Development phase
- 71
- Enrollment target
NCT04195906 is a Phase 3 study that has completed, run by Sanifit Therapeutics S. A.. The registered enrollment target is 71 participants.
The verdict
NCT04195906, a Phase 3 study, has completed, sponsored by Sanifit Therapeutics S. A..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 71 participants
- Enrollment target
Study Summary
The primary objectives are to assess the efficacy, safety, and tolerability of SNF472 compared to placebo when added to background care for the treatment of calciphylaxis (CUA).
Interventions
- DRUG Placebo Comparator: Placebo
- DRUG Experimental: SNF472
- DRUG Experimatenl SNF472 (Open-label)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2022-10-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04195906
The ClinicalTrials.gov registry entry for NCT04195906 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanifit Therapeutics S. A., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Comparator: Placebo is the first listed.
NCT04195906 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04195906 about?
NCT04195906 is a clinical study titled "Phase 3 Study of SNF472 for Calciphylaxis". The primary objectives are to assess the efficacy, safety, and tolerability of SNF472 compared to placebo when added to background care for the treatment of calciphylaxis (CUA).
What is the current status of trial NCT04195906?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 71 participants. The study started on 2020-02-12. Estimated completion is 2022-10-24.
What interventions are being tested in trial NCT04195906?
The interventions under investigation include: Placebo Comparator: Placebo (DRUG), Experimental: SNF472 (DRUG), Experimatenl SNF472 (Open-label) (DRUG).
Who is sponsoring clinical trial NCT04195906?
This trial is sponsored by Sanifit Therapeutics S. A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.